Jennifer Lew's Net Worth
$1.99 Million
Who is Jennifer Lew?
Jennifer Lew has an estimated net worth of $1.99 Million. This is based on reported shares across multiple companies, which include DYNAVAX TECHNOLOGIES CORP, ADURO BIOTECH, INC., and Annexon, Inc..
SEC CIK
Jennifer Lew's CIK is 0001465994
Past Insider Trading and Trends
2017 was Jennifer Lew's most active year for acquiring shares with 10 total transactions. Jennifer Lew's most active month to acquire stocks was the month of January. 2017 was Jennifer Lew's most active year for disposing of shares, totalling 15 transactions. Jennifer Lew's most active month to dispose stocks was the month of August. 2021 saw Jennifer Lew paying a total of $89,862.00 for 127,000 shares, this is the most they've acquired in one year. In 2016 Jennifer Lew cashed out on 44,119 shares for a total of $392,951.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.91
VP, Finance & PAO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
—
|
0
|
$2.54 | -$74,812.50 | 2.33K |
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADURO BIOTECH, INC. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.73 | -$54,829.72 | 135.16K |
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$2.66 | -$52,469.84 | 135.16K |
Scheduled
|
Apr 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
| -0.76% | -1.03K |
$2.93 | -$3,034.62 | 135.16K |
Dec 12
| |||
Form 4
| +84.07% | 62.2K |
$6.50 | -$36,545.56 | 136.19K |
Sep 12 - Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| +18.69% | 11.65K |
—
|
—
| 73.99K |
Dec 11
| |||
Form 4
|
—
|
0
|
$5.14 | -$57,020.70 | 62.34K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$4.89 | -$53,658.00 | 62.34K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
$5.72 | -$64,582.98 | 62.34K |
Scheduled
|
Oct 2
| ||
Form 4
| +46.35% | 19.74K |
$10.99 | -$39,076.49 | 62.34K |
Sep 12 - Sep 13
| |||
Form 4
|
—
|
0
|
$6.26 | -$71,830.44 | 42.59K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$6.50 | -$74,878.32 | 42.59K |
Scheduled
|
Aug 7
| ||
Form 4
|
—
|
0
|
$5.98 | -$123,792.00 | 42.59K |
Scheduled
|
Jul 3
| ||
Form 4
|
—
|
0
|
$6.01 | -$124,395.60 | 42.59K |
Scheduled
|
Jun 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
—
|
0
|
$7.89 | -$154,158.30 | 42.59K |
Scheduled
|
Nov 10
| ||
Form 4
| -2.08% | -905.00 |
$7.89 | -$90,608.90 | 42.59K |
Scheduled
|
Sep 19
| ||
Form 4
| +601.61% | 37.3K |
—
|
—
| 43.5K |
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
$13.27 | -$130,466.44 | 6.2K |
Scheduled
|
Jan 6
| ||
Form 4
| +210.00% | 4.2K |
$0.82 | $3,444.00 | 6.2K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
$15.34 | -$152,187.84 | 2K |
Scheduled
|
Dec 3
| ||
Form 4
| -42.36% | -1.47K |
$14.67 | -$187,127.80 | 2K |
Scheduled
|
Nov 18
| ||
Form 4
|
∞
| 2K |
$17.00 | $34,000.00 | 2K |
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Annexon, Inc. (ANNX) Snapshot price: $5.555
EVP & CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +79.75% | 36.41K |
$5.53 | -$14,339.29 | 82.06K |
Feb 16 - Feb 20
| |||
Form 4
| -3.81% | -1.81K |
$5.54 | -$10,021.86 | 45.65K |
Feb 12
| |||
Form 4
| -2.18% | -1.06K |
$3.84 | -$4,054.76 | 47.46K |
Jul 11
| |||
Form 4
| +64.23% | 18.98K |
—
|
—
| 48.52K |
Feb 16
| |||
Form 4
| -6.07% | -1.91K |
$6.31 | -$12,035.01 | 29.54K |
Feb 13 - Feb 14
| |||
Form 4
| +64.66% | 9.38K |
—
|
—
| 23.88K |
Jul 11
| |||
Form 4
| +625.00% | 12.5K |
—
|
—
| 14.5K |
Feb 11
| |||
Form 4
|
—
|
0
|
$13.75 | -$43,823.85 | 2K |
Scheduled
|
Sep 13
| ||
Form 4
|
—
|
0
|
$14.86 | -$51,625.35 | 2K |
Scheduled
|
May 27
| ||
Form 4
|
—
|
0
|
$17.97 | -$104,733.98 | 2K |
Scheduled
|
Mar 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
∞
| 2K |
$17.00 | $34,000.00 | 2K |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Boundless Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||